$IBO CO-founder to share his results at a global event
The company recently announced that DR Alberto Sola, CO-Founder of Universal Ibogaine, will present his recent findings in the title Ibogaine Hydrochloride and Acute Opioid Detox.
News24
$IBO is playing a fundamental role in the TSXV market Let’s go fellow shareholders of $IBO it is the day to be proud of yourself for trusting in $IBO, I am so enlivened to see this stock reaching the heights it was always meant to reach
$IBO the apex stock in the market, waiting for your investment
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is expanding in leaps and bounds in the market, shares are effectively trading at $0.0400 with zero loss percentage
$IBO on an unbelievable stock rally today on the TSX-V
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 10% at $0.0500 with sizeable ascent
Universal Ibogaine’s stock approved by borse Frankfurt
UI's common shares have been listed for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt, under the ticker symbol "JC4". In Canada, UI will continue to trade on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the ticker symbol IBOGF.
$IBO destined to be on top of the TSX-V index
$IBO is one of the handpicked penny stocks in the market today and is racing ahead with full speed, the stock’s financial figures are pretty neat and is expected achieve great heights in the days to come, shares are trading yesterday at $0.0500 with a distinctive spike
$IBO a promising stock investment in the TSX-V
$IBO one of the TSX-V’S finest stocks is trading with an uphill incline and is catering twofold revenue to the investors already the shares are trading
Nick Karos thrilled by listing of UI on Frankfurt stock exchange
UI CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
$IBO a trust worthy stock to keep up your portfolio’s credibilit
$IBO may be a pretty good stock to carry considering its high yielding capability and mounting optimistic candles within the momentum graph, the stock has delivered a lot of harvest and is presently commercialism at $0.05
$IBO Stock StatementUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $145K+ in the last 3 months. The average volume of the company in the last 10 days is $112K with $190.74M share outstanding. The stock price when the market opened was $0.05
$HEM volume increases
Hemostemix Inc. is a biotechnology company listed on TSX-V with ticker symbol $HEM has shown growth in its volume. Today the volume is 21.30K.
Universal Ibogaine Inc. CEO’s ecstatic to work with Blue Digital
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$HMTXF going up in flash on the OTC
$HMTXF today marked quite an impressive opening in the otc market and is currently trading with a steady pace at $0.1960 with a notable spike
Hemostemix hires new financial advisor to the family
Mr. Rick Groome who has effectively settled 2 securities firm, helping many successful biotechnology companies in providing funds over the last three decades has joined hemostemix as a special financial advisor.
$IBO announced a vital addition of clinical trials directorJulie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO stock analysis
Universal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of 138 K+ in the last 50 days . The average volume of the company in the last 10 days is $88.98K with $190.74M share outstanding. The stock price when the market opened was $0.05
$IBO’S CEO comments on the H.C Wainwright
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
$HEM recoups legal guardianship of its lost intellectual The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 clinical trial data in North America and South Africa.
Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest stock making heavy profit.
Click below link to know more
“An investor without investment ideas is like a traveler without so keep Update your ideas with the new addition of $IBO
Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market
$IBOGF Market AwarenessUniversal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF, currently sits at $0.0341 with the average market volume of 5k+
Presentation of Dr. Alberto Sola on the Research to Reality ConfDr. Alberto Sola, the co-founder of $IBOGF is going to present his latest findings in a panel titled “Ibogaine Hydrochloride and Acute Opioid Detox”.
